GE shares jump again as Wall Street loves Danaher deal: Stock no longer has 'downside risk'

A day after General Electric's surprise announcement of a biopharma sale to Danaher, Wall Street crowed about the embattled industrial conglomerate's $21.4 billion deal.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.